Kinetics of immune responses to influenza virus-like particles and dose-dependence of protection with a single vaccination
about
Virus-like particle vaccine containing hemagglutinin confers protection against 2009 H1N1 pandemic influenzaVirus-like particle vaccine protects against 2009 H1N1 pandemic influenza virus in miceA pandemic H1N1 influenza virus-like particle vaccine induces cross-protection in mice.Cutaneous immunization: an evolving paradigm in influenza vaccinesChemical-free inactivated whole influenza virus vaccine prepared by ultrashort pulsed laser treatmentAn Intranasal Virus-Like Particle Vaccine Broadly Protects Mice from Multiple Subtypes of Influenza A Virus.Progress in developing virus-like particle influenza vaccines.Advances in novel influenza vaccines: a patent review.New strategies for the development of H5N1 subtype influenza vaccines: progress and challenges.Microneedle and mucosal delivery of influenza vaccines.Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skinEnhanced memory responses to seasonal H1N1 influenza vaccination of the skin with the use of vaccine-coated microneedles.Host responses in human skin after conventional intradermal injection or microneedle administration of virus-like-particle influenza vaccine.Changes in human Langerhans cells following intradermal injection of influenza virus-like particle vaccines.Roles of major histocompatibility complex class II in inducing protective immune responses to influenza vaccinationIntradermal vaccination with influenza virus-like particles by using microneedles induces protection superior to that with intramuscular immunization.Influenza M2 virus-like particles confer a broader range of cross protection to the strain-specific pre-existing immunityDose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles.Characterization of a mutant Escherichia coli heat-labile toxin, LT(R192G/L211A), as a safe and effective oral adjuvant.Viruslike particle vaccine induces protection against respiratory syncytial virus infection in mice.Influenza virus-like particles coated onto microneedles can elicit stimulatory effects on Langerhans cells in human skin.Virus-Like Nanoparticle Vaccine Confers Protection against Toxoplasma gondii.Stability of influenza vaccine coated onto microneedles.Intranasal Immunization with Influenza Virus-Like Particles Containing Membrane-Anchored Cholera Toxin B or Ricin Toxin B Enhances Adaptive Immune Responses and Protection against an Antigenically Distinct Virus.Protective CD8 T cell-mediated immunity against influenza A virus infection following influenza virus-like particle vaccination.Mucosal adjuvants for influenza virus-like particle vaccine.MyD88 plays an essential role in inducing B cells capable of differentiating into antibody-secreting cells after vaccination.Virus-like particle vaccine protects against H3N2 canine influenza virus in dog.Oral vaccination with inactivated influenza vaccine induces cross-protective immunity.Influenza M1 VLPs containing neuraminidase induce heterosubtypic cross-protection.Distinct B-cell populations contribute to vaccine antigen-specific antibody production in a transgenic mouse model.Heterologous prime-boost immunization regimens using adenovirus vector and virus-like particles induce broadly neutralizing antibodies against H5N1 avian influenza viruses.Immunogenicity and efficacy of replication-competent recombinant influenza virus carrying multimeric M2 extracellular domains in a chimeric hemagglutinin conjugate.Distinct Effects of Monophosphoryl Lipid A, Oligodeoxynucleotide CpG, and Combination Adjuvants on Modulating Innate and Adaptive Immune Responses to Influenza Vaccination.Vaccination with Combination DNA and Virus-Like Particles Enhances Humoral and Cellular Immune Responses upon Boost with Recombinant Modified Vaccinia Virus Ankara Expressing Human Immunodeficiency Virus Envelope Proteins.Vaccination of lambs against Haemonchus contortus with the recombinant rHc23. Effect of adjuvant and antigen dose.The Mucosal Vaccine Adjuvant LT(R192G/L211A) or dmLTHuman β-defensin 2 plays a regulatory role in innate antiviral immunity and is capable of potentiating the induction of antigen-specific immunity
P2860
Q28741801-3A8D37F5-E2FA-4BBC-B682-2DBC220527EAQ28748950-E197269A-CD67-4CD2-8987-B98EC3CB4321Q30357052-CF3261F4-F532-4F09-ACA6-7D44CA90C5C3Q30358895-9544C0BB-A1B7-468C-98A0-7D87E6572A38Q30368920-C4DCDBFF-7FD7-4505-9637-C32FE1247321Q30377023-122C53DC-514D-4F7C-95BC-B9BD6680CE2BQ30386640-63CF135D-9654-487C-ACC6-96F08396018DQ30388514-AF0076A1-845B-441D-819B-AE27A809347BQ30407424-ECB9A047-48EC-41A7-AF63-1C5CA35121C8Q30418015-C42BDF39-189E-4450-A68A-EDBEF1575207Q33506637-1B2A14D9-3B00-4A25-A7DD-EF10D00A8AA9Q33557050-8FDB8732-2031-4CEE-9039-4BF2C468E155Q33563977-226A574D-018B-41BF-951A-C799AF077C0AQ33682225-FA83A4B4-A353-46EF-946A-EEEED581B1B8Q33900222-4FFA3A3D-8848-4D2B-8FCD-012C7629D136Q33964159-8B78D524-1855-49A2-AF8A-AA7553BC09F3Q34254359-24699288-5181-4BD3-A3EB-359106F98034Q34288194-A1C96522-6CCA-4FBA-B86A-01693A5EA477Q35066293-04AE02DD-0DB2-4212-A2B3-DDED9EBBF1F3Q35188476-46A33ADA-467A-4E58-BCA3-39A40093FD53Q36020905-79C9EFB0-B877-4C03-97C0-BA3D47550841Q36109262-3CB35075-584E-4F6C-B75F-AD848BB688D9Q36650284-293EC546-F7A8-452D-8A31-837C925E315FQ36846046-EC778D6F-7D19-4920-A2E7-907665CF56B8Q37184801-59F9E809-BBC4-4E3D-845A-EB57ED2FDB07Q37404044-8FFC71CB-DCA9-40E1-A4E6-CA10EE3DA824Q38725392-DF0B424E-E9D1-4FCA-B54F-7454A7A8984EQ39204975-16B6A74E-7D68-4696-B2A4-4154E7248631Q41378982-88B28372-7B47-41BA-88CC-983676EA0F7BQ41378999-816401E5-7F59-408F-998A-9EA67F6B2EB1Q42230447-C869C58C-F224-4C24-ACC4-F1E6ED12286DQ42286975-414450EF-8033-42B1-83C9-D67A1DA42605Q45325239-AAA54FB8-EF04-4D9F-A1F3-66880CAF544EQ47143691-E9B6D996-F195-4C21-AE45-552031DFEDF5Q47276928-E02B3E76-1103-444D-8A5B-9AC46E80352BQ51743473-D649B1D6-19FE-4BE5-852E-D7D67EA3C74EQ57945015-C299D774-0A4D-462D-9153-09DEC74578ACQ58795888-7C5E3D94-899D-4A06-BFC5-7FD3321D1574
P2860
Kinetics of immune responses to influenza virus-like particles and dose-dependence of protection with a single vaccination
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Kinetics of immune responses t ...... tion with a single vaccination
@en
Kinetics of immune responses t ...... ion with a single vaccination.
@nl
type
label
Kinetics of immune responses t ...... tion with a single vaccination
@en
Kinetics of immune responses t ...... ion with a single vaccination.
@nl
prefLabel
Kinetics of immune responses t ...... tion with a single vaccination
@en
Kinetics of immune responses t ...... ion with a single vaccination.
@nl
P2093
P2860
P356
P1433
P1476
Kinetics of immune responses t ...... tion with a single vaccination
@en
P2093
Dae-Goon Yoo
Fu Shi Quan
Jae-Min Song
John D Clements
Richard W Compans
Sang-Moo Kang
P2860
P304
P356
10.1128/JVI.02035-08
P407
P577
2009-02-11T00:00:00Z